ALB and cancer: In conclusion, although further study with a larger number of cases in a multi-institutional setting is required, our present results suggest that patient serum albumin level and comorbidity status have a substantial influence on the chemotherapeutic outcome in very elderly cancer patients, particularly in those aged over 75 years.